A 20‐Year Epidemiological Study of Pneumococcal Meningitis
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
We conducted a retrospective analysis of 55 community-acquired Streptococcus pneumoniae meningitis illnesses in Huntington, West Virginia, from 1978 to 1997. Fourteen (36.8%) of 38 adults and 2 (11.8%) of 17 children died. Serotypes 6, 23, 3, and 18 accounted for 20 (41.7%) of 48 strains available for serotyping. Of 40 strains available for antimicrobial susceptibility testing, 1 serotype 19 and 1 serotype 23 strain showed intermediate resistance and a second serotype 23 strain showed high resistance to penicillin; all three patients survived. The case-fatality rates among adults who received penicillin alone, gentamicin in combination, or vancomycin and cephalosporin together were 57.1%, 55.5%, and 60%, respectively, and among those who received chloramphenicol or a third-generation cephalosporin, they were 11.1% or nil, respectively. No child died who received chloramphenicol or vancomycin. Two (33%) of 6 children died who received a third-generation cephalosporin; both were critically ill when initially treated. No child and one adult had received pneumococcal vaccine prior to becoming ill.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite reported successes, there has been a report of cases of invasive H. influenzae type b disease in children previously vaccinated in Nottingham, United Kingdom (117), perhaps because in the United Kingdom, children are vaccinated at 2, 3, and 4 months of age without the administration of a booster dose (295).”
From Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010) · cites this paper as [295]
Citations
Cites
Acute Bacterial Meningitis in Adults -- A Review of 493 Episodes
Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S., & Swartz, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280104 · Cited by 1,344 · cited 2×
“Age, an impaired level of consciousness, and seizures within the first 24 hours proved the most important prognostic factors [28].”
BackgroundOutcomes of bacterial meningitis in children: a meta-analysis
BARAFF, L. J., LEE, S. I., & SCHRIGER, D. L. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199305000-00008 · Cited by 495 · cited 4×
“These case-fatality rates do not differ from those in other industrialized populations [27-29].”
BackgroundInfluentialDoern, G. V., Brueggemann, A., Holley, H. P., & Rauch, A. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1208 · Cited by 482 · cited 1×
“resistant strains emerged also during this time period, including strains that exhibited resistance to the cephalosporin class of antibiotics [21, 40-44].”
BackgroundRennels, M. B., Edwards, K. M., Keyserling, H. L., Reisinger, K. S., Hogerman, D. A., Madore, D. V., Chang, I., Paradiso, P. R., Malinoski, F. J., & Kimura, A. (1998) · Pediatrics · doi:10.1542/peds.101.4.604 · Cited by 392 · cited 1×
“A protein conjugate vaccine currently under development appears to be highly antigenic in infants and children [50-55].”
BackgroundCost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly People
Sisk, J. E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160053038 · Cited by 362 · cited 1×
“It continues to be underused even though the cost benefit of he vaccine has been well established [49].”
BackgroundKlugman, K. P., Friedland, I. R., & Bradley, J. S. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1988 · Cited by 240
Davidson, M., Parkinson, A. J., Bulkow, L. R., Fitzgerald, M. A., Peters, H., & Parks, D. J. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.2.368 · Cited by 231 · cited 2×
“incidence was 84 cases/100,000 [32].”
BackgroundClavo‐Sanchez, A. J., Giron‐Gonzalez, J. A., Lopez‐Prieto, D., Canueto‐Quintero, J., Sanchez‐Porto, A., Vergara‐Campos, A., Marin‐Casanova, P., & Cordoba‐Dona, J. A. (1997) · Clinical Infectious Diseases · doi:10.1086/513628 · Cited by 172
Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci
Viladrich, P. F., Gudiol, F., Liñares, J., Rufi, G., Ariza, J., & Pallarés, R. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90061-7 · Cited by 155 · cited 1×
“With the worldwide emergence of penicillin-nonsusceptible (resistant) pneumococci over the last several years, treatment regimens now include the cephalosporin class of antibiotics and vancomycin [11-13].”
BackgroundOutcomes of bacterial miningitis in children: A meta-analysis
Paik, L. (1993) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)81289-2 · Cited by 149
Pneumococcal Meningitis in Children: Prognostic Indicators and Outcome
Kornelisse, R. F., Westerbeek, C., Spoor, A. B., van der Heijde, B., Spanjaard, L., Neijens, H. J., & de Groot, R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1390 · Cited by 142 · cited 3×
“Adults usually die from cardiorespiratory failure and children from neurological complications [9].”
BackgroundImmunogenicity of heptavalent pneumococcal conjugate vaccine in infants
Anderson, E. L., Kennedy, D. J., Geldmacher, K. M., Donnelly, J., & Mendelman, P. M. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)80130-2 · Cited by 141 · cited 1×
“A protein conjugate vaccine currently under development appears to be highly antigenic in infants and children [50-55].”
BackgroundBacterial Meningitis in the Elderly
Gorse, G. J. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350200107016 · Cited by 140 · cited 1×
“They are higher in adults than in children [2-7].”
BackgroundJorgensen, J. H., Ferraro, M. J., McElmeel, M. L., Spargo, J., Swenson, J. M., & Tenover, F. C. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.1.159-163.1994 · Cited by 138 · cited 2×
“[23], except for cefuroxime, which was interpreted with the recommendations of Barry et al.”
BackgroundMethodPneumococcal Disease in a Medium-Sized Community in the United States
Mufson, M. A. (1982) · JAMA · doi:10.1001/jama.1982.03330120044028 · Cited by 129
Self-citationPneumococcal disease among children in a rural area of West Africa
O'DEMPSEY, T. J. D., MCARDLE, T. F., LLOYD-EVANS, N., BALDEH, I., LAWRENCE, B. E., SECKA, O., & GREENWOOD, B. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199605000-00010 · Cited by 126 · cited 2×
“By contrast, among indigenous native populations and in developing countries, case-fatality rates exceed by 15- to 100fold the annual incidences in industrialized countries [32-34].”
BackgroundJorgensen, J. H., Howell, A. W., & Maher, L. A. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.1.109-114.1991 · Cited by 122 · cited 1×
“It provides an accurate, reproducible, and efficient procedure for determining penicillin MICs [22-24].”
BackgroundThe Pneumococcal Vaccine After 15 Years of Use
Hirschmann, J. V. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420040023005 · Cited by 108
Bradley, J. S., & Scheid, W. M. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_2.s213 · Cited by 103 · cited 3×
“for the treatment of meningitis caused by penicillin-resistant pneumococci, especially in children [39, 45].”
BackgroundResultDaum, R. S., HOGERMAN, D. A., Rennels, M. B., Bewley, K., Malinoski, F. J., Rothstein, E. P., Reisinger, K. S., Block, S. L., KEYSERLING, H. L., & Steinhoff, M. C. (1997) · The Journal of Infectious Diseases · doi:10.1086/514063 · Cited by 92 · cited 1×
“A protein conjugate vaccine currently under development appears to be highly antigenic in infants and children [50-55].”
BackgroundHospital-Based Pneumococcal Immunization
Fedson, D. S. (1990) · JAMA · doi:10.1001/jama.264.9.1117 · Cited by 81
King, J. C., Vink, P., Farley, J. J., Smilie, M., Parks, M. G., & Lichenstein, R. (1997) · PEDIATRICS · doi:10.1542/peds.99.4.575 · Cited by 80 · cited 1×
“A protein conjugate vaccine currently under development appears to be highly antigenic in infants and children [50-55].”
BackgroundMolecular Epidemiology of Drug-Resistant Pneumococci: Toward an International Approach
Hermans, P. W. M., Sluijter, M., Dejsirilert, S., Lemmens, N., Elzenaar, K. P., van Veen, A., Goessens, W. H. F., & de Groot, R. (1997) · Microbial Drug Resistance · doi:10.1089/mdr.1997.3.243 · Cited by 73 · cited 1×
“resistant strains emerged also during this time period, including strains that exhibited resistance to the cephalosporin class of antibiotics [21, 40-44].”
BackgroundPneumococcal resistance patterns in Europe
Pradier, C., Dunais, B., Carsenti-Etesse, H., & Dellamonica, P. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01708553 · Cited by 72
Pneumococcal Vaccine After 15 Years of Use: Another View
Fedson, D. S. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.22.2531 · Cited by 71
Salwén, K. M., Vikerfors, T., & Olcén, P. (1987) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548709032371 · Cited by 66 · cited 1×
“Of the persons who survive pneumococcal meningitis, 50% develop some neurological dysfunction that may persist for only a week or last as long as a lifetime [2, 14-16].”
BackgroundKirkpatrick, B., Reeves, D. S., & MacGowan, A. P. (1994) · Journal of Infection · doi:10.1016/s0163-4453(94)90698-x · Cited by 65 · cited 3×
“It occurs in all age groups, especially young children, adults with underlying diseases, the elderly, and persons with immunologic disorders [2].”
BackgroundZeleny, R., Altmann, F., & Praznik, W. (1997) · Analytical Biochemistry · doi:10.1006/abio.1996.9973 · Cited by 61 · cited 1×
“With the worldwide emergence of penicillin-nonsusceptible (resistant) pneumococci over the last several years, treatment regimens now include the cephalosporin class of antibiotics and vancomycin [11-13].”
BackgroundDeaths in Bacteremic Pneumococcal Pneumonia
Örtqvist, Å., Kalin, M., Julander, I., & Mufson, M. A. (1993) · CHEST Journal · doi:10.1378/chest.103.3.710 · Cited by 54 · cited 1×
“This retrospective study of pneumococcal meningitis constitutes part of the long-term surveillance of community-acquired invasive pneumococcal disease in Huntington, West Virginia, and environs, encompassing 20 years from 1978 to 1997 [17-21].”
BackgroundSelf-citationEpidemiology of Pneumococcal Serotypes and Conjugate Vaccine Formulations
Butler, J. C. (1997) · Microbial Drug Resistance · doi:10.1089/mdr.1997.3.125 · Cited by 54
SIGURDARDOTTIR, S. T., Vidarsson, G., Guðnason, Þ., Kjartansson, S., Kristinsson, K. G., Jónsson, S., Valdimarsson, H., Schiffman, G., Schneerson, R., & Jónsdóttir, I. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199707000-00009 · Cited by 45 · cited 1×
“A protein conjugate vaccine currently under development appears to be highly antigenic in infants and children [50-55].”
BackgroundClinical evaluation of pneumococcal meningitis in adults over a twelve-year period
Bruyn, G. A. W., Kremer, H. P. H., de Marie, S., Padberg, G. W., Hermans, J., & van Furth, R. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01963754 · Cited by 44
Chesney, P. J., Wilimas, J. A., Presbury, G. J., Abbasi, S., Leggiadro, R. J., Davis, Y., Day, S. W., Schutze, G. E., & Wang, W. C. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70107-9 · Cited by 43
Pneumococcal Meningitis in Adults
Kragsbjerg, P., Källman, J., & Olcén, P. (1994) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549409008633 · Cited by 39 · cited 1×
“They are higher in adults than in children [2–7].”
BackgroundBacterial Meningitis in Elderly Patients: Clinical Picture and Course
RASMUSSEN, H. H., SØRENSEN, H. T., MØLLER-PETERSEN, J., MORTENSEN, F. V., & NIELSEN, B. (1992) · Age and Ageing · doi:10.1093/ageing/21.3.216 · Cited by 39
Liñares, J., Pérez, J. L., Garau, J., Murgui, L., & Martín, R. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/13.4.353 · Cited by 38 · cited 1×
“These case-fatality rates do not differ from those in other industrialized populations [27-29].”
BackgroundEpidemiology of post-neonatal bacterial meningitis in Cape Town children.
Hussey, G. D., Schaaf, H. S., Hanslo, D., Hitchcock, J., Coetzee, G. J., Pitout, J. D. D., Malan, H., & Donald, P. R. (1997) · PubMed · Cited by 38
Istre, G. R., Humphreys, J., Albrecht, K. D., Thornsberry, C., Swenson, J. M., & Hopkins, R. S. (1983) · Journal of Clinical Microbiology · doi:10.1128/jcm.17.3.472-475.1983 · Cited by 37 · cited 1×
“They are higher in adults than in children [2-7].”
BackgroundScholz, H., Hofmann, T., Noack, R., Edwards, D. J., & Stoeckel, K. (1998) · Chemotherapy · doi:10.1159/000007106 · Cited by 34 · cited 1×
“Other investigators found n worse case-fatality rates than we did [39, 46].”
ResultUrwin, G., Yuan, M. F., Hall, L. M. C., Brown, K. R., Efstratiou, A., & Feldman, R. A. (1996) · Epidemiology and Infection · doi:10.1017/s0950268800001175 · Cited by 33 · cited 4×
“1 cases/100,000 persons [3].”
BackgroundResultInfluentialFriedland, I. R., Shelton, S., & McCracken, G. H. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.6.1619-1621.1993 · Cited by 30
Letson, C. W. (1992) · American journal of diseases of children · doi:10.1001/archpedi.1992.02160170040013 · Cited by 30 · cited 1×
“Of the persons who survive pneumococcal meningitis, 50% develop some neurological dysfunction that may persist for only a week or last as long as a lifetime [2, 14-16].”
BackgroundFedson, D. S. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1371 · Cited by 22
THE DESCRIPTIVE EPIDEMIOLOGY OF PNEUMOCOCCAL MENINGITIS IN NEW YORK CITY
Henneberger, P. K., GALAIDI, E. I., & Marr, J. S. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113566 · Cited by 21 · cited 1×
“They are higher in adults than in children [2-7].”
BackgroundComparison of susceptibility test methods to detect penicillin-resistant Streptococcus pneumoniae
Clark, R. B., Giger, O., & Mortensen, J. E. (1993) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(93)90099-s · Cited by 21 · cited 1×
“It provides an accurate, reproducible, and efficient procedure for determining penicillin MICs [22-24].”
BackgroundPattern of bacterial meningitis in Italy, 1994
Salmaso, S., Mastrantonio, P., Scuderi, G., Congiu, M. E., Pompa, M. G., Stroffolini, T., & Squarcione, S. (1997) · European Journal of Epidemiology · doi:10.1023/a:1007303502274 · Cited by 19
Antimicrobial resistance: implications for managing respiratory failure
Chenoweth, C., & Lynch, J. P. (1997) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-199703000-00013 · Cited by 18 · cited 1×
“resistant strains emerged also during this time period, including strains that exhibited resistance to the cephalosporin class of antibiotics [21, 40-44].”
BackgroundD'Amato, R. F., Swenson, J. M., McKinley, G. A., Hochstein, L. H., Wallman, A. A., Cleri, D. J., Mastellone, A. J., Fredericks, L., Gonzalez, L., & Pincus, D. (1987) · Journal of Clinical Microbiology · doi:10.1128/jcm.25.9.1753-1756.1987 · Cited by 16 · cited 1×
“[36] found that four factors contributed to predicting outcome: the Glasgow coma scale score, age, CSF glucose levels, and concomitant pneumonia.”
BackgroundEmergence of Penicillin-Resistant Invasive Pneumococci in a Single American Community
Stanek, R. J., & Mufson, M. A. (1995) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199510000-00004 · Cited by 13 · cited 3×
“opportunity for assessing the evolving clinical features of disease and identifying trends in its occurrence and treatment [17, 18, 20, 21].”
BackgroundSelf-citationRELATIVELY PENICILLIN-RESISTANT PNEUMOCOCCAL MENINGITIS IN A BRAZILIAN INFANT
Marques, H. H. D. S., Yamamoto, M., Sakane, P. T., Caiaffa-Filho, H., & Mendes, C. M. F. (1988) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198806000-00017 · Cited by 11 · cited 1×
“The strongest prognostic factors among children are coma, respiratory distress, shock, and low CSF glucose levels [9, 37].”
BackgroundBarry, A. L., & FUCHS, P. C. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.10.2609-2612.1996 · Cited by 9
ENHANCED p24 ANTIGEN DETECTION IN SERA FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN
Walter, E. B., Weinhold, K. J., & Wilfert, C. M. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199301000-00019 · Cited by 7
Dagan, R. (1994) · PubMed · Cited by 6
The approach to treatment of invasive pneumococcal disease in the 1990s.
Knapp, K. M., & Schutze, G. E. (1997) · PubMed · Cited by 3
[Epidemiology of primary bacterial meningitis].
Hoen, B. (1994) · PubMed · Cited by 2
Research works printed but not linked: 3
- Kirkpatrick B, 1994, J Clin Microbiol, 32, 63
- Urwin G, 1991, J Clin Microbiol, 29, 14
- Rasmussen HH, 1994, Israel. Isr J Med Sci, 30, 5
Cited by
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
“Gram staining correctly identifies the pathogen in 69 to 93% of patients with pneumococcal meningitis (11, 15, 49, 68, 95, 148, 208, 242, 286, 294, 340).”
BackgroundKastenbauer, S., & Pfister, H.-W. (2003) · Brain · doi:10.1093/brain/awg113 · Cited by 482
Pathogenesis and pathophysiology of pneumococcal meningitis
Koedel, U., Scheld, W. M., & Pfister, H.-W. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00450-4 · Cited by 380
Weisfelt, M., van de Beek, D., Spanjaard, L., Reitsma, J. B., & de Gans, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70288-x · Cited by 313
Bacteremic and Nonbacteremic Pneumococcal Pneumonia A Prospective Study
Musher, D. M., Alexandraki, I., Graviss, E. A., Yanbeiy, N., Eid, A., Inderias, L. A., Phan, H. M., & Solomon, E. (2000) · Medicine · doi:10.1097/00005792-200007000-00002 · Cited by 217
Metadata
- Authors
- Stanek, R. J., & Mufson, M. A.
- Affiliations
- Marshall University (US)
- Corresponding author
- Mufson, Maurice A.
- ORCID
- Mufson, Maurice A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-06
- Volume
- 28
- Issue
- 6
- Pages
- 1265-1272
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2137414109
- Cited by
- 59
- References
- 55
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 2
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- pneumococcal meningitis, Streptococcus pneumoniae, community-acquired meningitis, case fatality rate, serotypes, antimicrobial resistance, penicillin resistance, vancomycin, gentamicin, chloramphenicol, third-generation cephalosporins, pneumococcal vaccine, children, adults
- MeSH terms
- Adolescent, Adult, Aged, Bacterial Vaccines, Cerebrospinal Fluid Proteins, Child, Child, Preschool, Humans, Infant, Infant, Newborn, Meningitis, Pneumococcal, Microbial Sensitivity Tests, Middle Aged, Streptococcus pneumoniae, Time Factors, Incidence, Pneumococcal Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.